-
Antibodies, Research Grade BiosimilarsPanitumumab Biosimilar, L234A L235A P329G (LALAPG) Fc Silent Mutant | C012P.LA
$650.00Panitumumab Biosimilar, L234A L235A P329G (LALAPG) Fc Silent Mutant. Panitumab biosimilar CHO stable cell line is available for licensing to manufacture the panitumumab biosimilar protein. The research grade panitumab…
Select optionsQuick View - Antibodies, Research Grade Biosimilars
Panitumumab Biosimilar, Endotoxin 0.05 EU/mg | C012P.05
$720.00 – $1,440.00Panitumumab Biosimilar, Endotoxin 0.05 EU/mg. Panitumab biosimilar CHO stable cell line is available for licensing to manufacture the panitumumab biosimilar protein. The research grade panitumab biosimilar protein is for…
Select optionsQuick View - Antibodies, Research Grade Biosimilars
Eculizumab Biosimilar, N297A Mutant | C022P.NA
$650.00Eculizumab Biosimilar, N297A Mutant. Eculizumab biosimilar CHO stable cell line is available for licensing to manufacture the eculizumab biosimilar protein. The research grade eculizumab biosimilar protein is for research…
Select optionsQuick View - Antibodies, Research Grade Biosimilars
Eculizumab Biosimilar, L234A L235A P329G (LALAPG) Fc Silent Mutant | C022P.LA
$650.00Eculizumab Biosimilar, L234A L235A P329G (LALAPG) Fc Silent Mutant. Eculizumab biosimilar CHO stable cell line is available for licensing to manufacture the eculizumab biosimilar protein. The research grade eculizumab…
Select optionsQuick View - Antibodies, Research Grade Biosimilars
Infliximab Biosimilar, N297A Mutant | C011P.NA
$375.00Infliximab Biosimilar, N297A Mutant. Infliximab biosimilar CHO stable cell line is available for licensing to manufacture the Infliximab biosimilar protein. The research grade infliximab biosimilar protein is for research…
Select optionsQuick View - Antibodies, Research Grade Biosimilars
Infliximab Biosimilar, L234A L235A P329G (LALAPG) Fc Silent Mutant | C011P.LA
$375.00Infliximab Biosimilar, L234A L235A P329G (LALAPG) Fc Silent Mutant. Infliximab biosimilar CHO stable cell line is available for licensing to manufacture the Infliximab biosimilar protein. The research grade infliximab…
Select optionsQuick View - Antibodies, Research Grade Biosimilars
Camrelizumab Biosimilar, Anti-human PD-1 Antibody | C028P
$175.00 – $1,600.00Camrelizumab Biosimilar, PD-1 Monoclonal Antibody. The research grade Camrelizumab biosimilar protein is for research use only (RUO). Recombinant human IgG4 isotype controls are available. Condition of sample preparation and…
Select optionsQuick View - Anti-Mouse Antibodies (In Vivo), Antibodies
Anti-mouse CTLA-4 Antibody (Clone: 9D9, CD152) | PA007380.m2aLA
$150.00 – $900.00Recombinant mouse IgG2b isotype control, Recombinant mouse IgG2c LALAPG isotype control, and Recombinant mouse IgG2a LALAPG isotype control are available. Condition of sample preparation and optimal sample dilution should be determined experimentally by…
Select optionsQuick View - Antibodies, Antibody Isotype Controls
Anti-HEL VHH-mIgG2a Fc Isotype Control Antibody(Clone: D3-L11) | PA007165.m2a
$350.00Recombinant anti-HEL VHH isotype control antibodies (nanobody, single-domain antibody, or the variable domain of heavy chain antibody) good for in vitro and in vivo studies. Low or no specific…
Select optionsQuick View - Antibodies, Antibody Isotype Controls
HEL D1.3 Human IgG2 Isotype Control Antibody | PA007153.h2
$595.00Recombinant anti-HEL isotype control antibodies and Fc silenced mutants from clone HEL D1.3 good for in vitro and in vivo studies. Low or no specific binding to human, rat,…
Select optionsQuick View - Anti-Human Antibodies for Flow Cytometry, Antibodies
APC/Cy7 Anti-human CD3e Antibody for Flow Cytometry | PA007236
$110.00 – $260.00Recombinant mouse IgG1 isotype control is available. Condition of sample preparation and optimal sample dilution should be determined experimentally by the investigator.
Select optionsQuick View - Anti-Human Antibodies for Flow Cytometry, Antibodies
iFluor 700 Anti-human CD3e Antibody for Flow Cytometry | PA007235
$100.00 – $200.00Recombinant mouse IgG1 isotype control is available. Condition of sample preparation and optimal sample dilution should be determined experimentally by the investigator.
Select optionsQuick View
Shop by Category
